Literature DB >> 29247600

SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity than SpCas9 or FnCpf1 in Human Cells.

Haihua Xie1, Lianchao Tang1, Xiubin He1, Xiexie Liu1, Chenchen Zhou1, Junjie Liu1, Xianglian Ge1, Jin Li1, Changbao Liu2, Junzhao Zhao2, Jia Qu1, Zongming Song1,3, Feng Gu1.   

Abstract

CRISPR/Cas9-mediated gene therapy holds great promise for the treatment of human diseases. The protospacer adjacent motif (PAM), the sequence adjacent to the target sequence, is an essential targeting component for the design of CRISPR/Cas9-mediated gene editing. However, currently, very few studies have attempted to directly study the PAM sequence in human cells. To address this issue, the authors develop a dual fluorescence reporter system that could be harnessed for identifying functional PAMs for genome editing endonuclease, including Cas9. With this system, the authors investigate the effects of different PAM sequences for SaCas9, which is small and has the advantage of allowing in vivo genome editing, and found only 5'-NNGRRT-3' PAM could induced sufficient target cleavage with multi-sites. The authors also found SaCas9 possesses higher activity than SpCas9 or FnCpf1 via plasmids (episomal) and chromosomes with integrated eGFP-based comparison. Taken together, the authors show that a dual fluorescence reporter system is a means to identifying a functional PAM and quantitatively comparing the efficiency of different genome editing endonucleases with the similar or identical target sequence in human cells.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CRISPR/Cas9; FnCpf1; PAM; activity; dual fluorescence reporter

Mesh:

Substances:

Year:  2018        PMID: 29247600     DOI: 10.1002/biot.201700561

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  18 in total

1.  Rationally engineered Staphylococcus aureus Cas9 nucleases with high genome-wide specificity.

Authors:  Yuanyan Tan; Athena H Y Chu; Siyu Bao; Duc Anh Hoang; Firaol Tamiru Kebede; Wenjun Xiong; Mingfang Ji; Jiahai Shi; Zongli Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

2.  Two high-fidelity variants: efSaCas9 and SaCas9-HF, which one is better?

Authors:  Jineng Lv; Haitao Xi; Xiujuan Lv; Yue Zhou; Jiahua Wang; Haoran Chen; Tong Yan; Jiang Jin; Junzhao Zhao; Feng Gu; Zongming Song
Journal:  Gene Ther       Date:  2022-01-31       Impact factor: 4.184

3.  Quantification of the affinities of CRISPR-Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences.

Authors:  Vladimir Mekler; Konstantin Kuznedelov; Konstantin Severinov
Journal:  J Biol Chem       Date:  2020-04-01       Impact factor: 5.157

4.  Comparison of efficiency and specificity of CRISPR-associated (Cas) nucleases in plants: An expanded toolkit for precision genome engineering.

Authors:  Oleg Raitskin; Christian Schudoma; Anthony West; Nicola J Patron
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

5.  Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice.

Authors:  Mirella Lo Scrudato; Karine Poulard; Célia Sourd; Stéphanie Tomé; Arnaud F Klein; Guillaume Corre; Aline Huguet; Denis Furling; Geneviève Gourdon; Ana Buj-Bello
Journal:  Mol Ther       Date:  2019-06-05       Impact factor: 11.454

6.  Efficient cleavage resolves PAM preferences of CRISPR-Cas in human cells.

Authors:  Lianchao Tang; Fayu Yang; Xiaoxue He; Haihua Xie; Xiaoyu Liu; Junhao Fu; Haitao Xi; Xiaosheng Lu; Changbao Liu; Zongming Song; Jia Qu; Junzhao Zhao; Feng Gu
Journal:  Cell Regen (Lond)       Date:  2019-10-28

Review 7.  Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update.

Authors:  Chengmei Sun; Luoan Shen; Zheng Zhang; Xin Xie
Journal:  Genes (Basel)       Date:  2020-07-23       Impact factor: 4.096

8.  Engineering the Direct Repeat Sequence of crRNA for Optimization of FnCpf1-Mediated Genome Editing in Human Cells.

Authors:  Li Lin; Xiubin He; Tianyuan Zhao; Lingkai Gu; Yeqing Liu; Xiaoyu Liu; Hongyan Liu; Fayu Yang; Mengjun Tu; Lianchao Tang; Xianglian Ge; Changbao Liu; Junzhao Zhao; Zongming Song; Jia Qu; Feng Gu
Journal:  Mol Ther       Date:  2018-09-01       Impact factor: 11.454

9.  The Development of an AAV-Based CRISPR SaCas9 Genome Editing System That Can Be Delivered to Neurons in vivo and Regulated via Doxycycline and Cre-Recombinase.

Authors:  Namrata Kumar; William Stanford; Christopher de Solis; Nigel D Abraham; Trieu-Mi J Dao; Sadiqa Thaseen; Anusha Sairavi; Cuauhtemoc Ulises Gonzalez; Jonathan E Ploski
Journal:  Front Mol Neurosci       Date:  2018-11-13       Impact factor: 5.639

10.  Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9.

Authors:  Hyung Suk Oh; Werner M Neuhausser; Pierce Eggan; Magdalena Angelova; Rory Kirchner; Kevin C Eggan; David M Knipe
Journal:  Elife       Date:  2019-12-02       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.